Hexaviral specific T-cells targeting parainfluenza, CMV, EBV, adenovirus, HHV6 and BKV used for prophylaxis and treatment of viral infections in patients post stem cell transplant
Year: 2019
Type: article
Study design: Clinical Trial
Source: Cytotherapy
Authors: M.D. Keller, K. Harris, P. Hanley, A. Abraham, B.J. Davila, N. Zhang, G. Sani, H. Lang, R. Childs, R. Jones, C. Bollard
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2946119041
